<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Hum Genet</journal-id><journal-title-group><journal-title>European Journal of Human Genetics</journal-title></journal-title-group><issn pub-type="ppub">1018-4813</issn><issn pub-type="epub">1476-5438</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">37985816</article-id><article-id pub-id-type="pmc">10853274</article-id>
<article-id pub-id-type="publisher-id">1493</article-id><article-id pub-id-type="doi">10.1038/s41431-023-01493-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Biallelic variants in the synaptic vesicle glycoprotein 2&#x2009;A are associated with epileptic encephalopathy</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1404-8887</contrib-id><name><surname>Al-Maawali</surname><given-names>Almundher</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Al-Murshedi</surname><given-names>Fathiya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Al-Futaisi</surname><given-names>Amna</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mansy</surname><given-names>Ahmed</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Al-Habsi</surname><given-names>Asila</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0139-8239</contrib-id><name><surname>Girisha</surname><given-names>Katta M.</given-names></name><address><email>g.kumar@squ.edu.om</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412846.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 9430</institution-id><institution>Department of Genetics, Sultan Qaboos University Hospital, </institution><institution>Sultan Qaboos University, </institution></institution-wrap>Muscat, Oman </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04wq8zb47</institution-id><institution-id institution-id-type="GRID">grid.412846.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 9430</institution-id><institution>Department of Genetics, College of Medicine and Health Sciences, </institution><institution>Sultan Qaboos University, </institution></institution-wrap>Muscat, Oman </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04wq8zb47</institution-id><institution-id institution-id-type="GRID">grid.412846.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 9430</institution-id><institution>Department of Child Health, College of Medicine and Health Sciences, </institution><institution>Sultan Qaboos University, </institution></institution-wrap>Muscat, Oman </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/049xx5c95</institution-id><institution-id institution-id-type="GRID">grid.412855.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0442 8821</institution-id><institution>Department of Nursing, </institution><institution>Sultan Qaboos University Hospital, </institution></institution-wrap>Muscat, Oman </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2024</year></pub-date><volume>32</volume><issue>2</issue><fpage>243</fpage><lpage>246</lpage><history><date date-type="received"><day>5</day><month>6</month><year>2023</year></date><date date-type="rev-recd"><day>21</day><month>9</month><year>2023</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>&#xA9; The Author(s), under exclusive licence to European Society of Human Genetics 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</copyright-statement></permissions><abstract id="Abs1"><p id="Par1">Synaptic Vesicle Glycoprotein 2&#x2009;A (SV2A) is a membrane protein of synaptic vesicles and the binding site of antiepileptic drug levetiracetam. Biallelic Arg383Gln is reported in a family with intractable epilepsy earlier. Here, we report on the second family with early onset drug resistant epilepsy. We identified homozygous Arg289Ter variant by exome sequencing that segregated with the phenotype in the family. The affected children in these two families are normal at birth and developed recurrent seizures beginning in the second month of life and developed secondary failure of growth and development. Knock out mice models earlier had replicated the human phenotype observed in these two families. These findings support that biallelic loss of function variants in <italic>SV2A</italic> result in early onset intractable epilepsy in humans.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Neurological disorders</kwd><kwd>Molecular biology</kwd><kwd>Genetics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#xA9; European Society of Human Genetics 2024</meta-value></custom-meta></custom-meta-group></article-meta></front>
</article>
</pmc-articleset>